Research into conolidine has led to discovery of the opioid receptor in the human body identified as ACKR3/CXCR7. ACKR3 appears to be the most wanted target for conolidine, which also disregards another 4 classical opioid receptors(3). Presented the system of action of conolidine contrary to opioids which subsequently would https://euripideso454jkl5.oblogation.com/profile